1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Fax: (011) 39-06-30486559
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy
Long-term results
Article first published online: 12 OCT 2004
DOI: 10.1002/cncr.20654
Copyright © 2004 American Cancer Society
Additional Information
How to Cite
Danesi, D. T., Arcangeli, G., Cruciani, E., Altavista, P., Mecozzi, A., Saracino, B. and Orefici, F. (2004), Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy. Cancer, 101: 2540–2548. doi: 10.1002/cncr.20654
Publication History
- Issue published online: 16 NOV 2004
- Article first published online: 12 OCT 2004
- Manuscript Revised: 10 AUG 2004
- Manuscript Accepted: 10 AUG 2004
- Manuscript Received: 21 APR 2004
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , , , , Radiochimiothérapie pour le traitement des cancers de vessie infiltrant le muscle : modalités, surveillance et résultats. Mise au point du comité de cancérologie de l’Association française d’urologie, Progrès en Urologie, 2012, 22, 1, 13
- 2, Re: Bladder Preservation Multimodality Therapy as an Alternative to Radical Cystectomy for Treatment of Muscle Invasive Bladder Cancer, The Journal of Urology, 2012, 187, 2, 473
- 3, , Selective bladder preservation with curative intent for muscle-invasive bladder cancer: A contemporary review, International Journal of Urology, 2012, 19, 5Direct Link:
- 4, , , , , , Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer, BJU International, 2011, 107, 10Direct Link:
- 5, , , Current management of muscle-invasive bladder cancer, Clinical and Translational Oncology, 2011, 13, 12, 855
- 6, , , , Combined modality treatment with bladder preservation for muscle invasive bladder cancer, Urologic Oncology: Seminars and Original Investigations, 2010, 28, 1, 14
- 7, , Current status of radiation therapy for bladder cancer, Expert Review of Anticancer Therapy, 2010, 10, 6, 895
- 8, , , , , New Italian guidelines on bladder cancer, based on the World Health Organization 2004 classification, BJU International, 2010, 106, 2Direct Link:
- 9, , , , , , , Treatment Results of Radiation Therapy for Muscle-Invasive Bladder Cancer, Strahlentherapie und Onkologie, 2010, 186, 4, 203
- 10
- 11, , , , , , Bladder Cryoablation in a Porcine Model: Evaluation of Three Surgical Approaches and Cryolesion Predictability, Journal of Endourology, 2009, 23, 3, 515
- 12, , , , , , , , 64-detector row CT cystography with virtual cystoscopy in the detection of bladder carcinoma: preliminary experience in selected patients, La radiologia medica, 2008, 114, 1, 52
- 13
- 14, , Bladder-sparing therapy for muscle-infiltrating bladder cancer, Nature Clinical Practice Urology, 2008, 5, 7, 368
- 15, , , , , , , , , , Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer, Cancer, 2008, 112, 1Direct Link:
- 16, , , , Conservative treatment in patients with muscle-invasive bladder cancer by transurethral resection, neoadjuvant chemotherapy with gemcitabine and cisplatin, and accelerated radiotherapy with concomitant boost plus concurrent cisplatin – assessment of response and toxicity., Reports of Practical Oncology & Radiotherapy, 2008, 13, 6, 300
- 17, High throughput molecular diagnostics in bladder cancer – on the brink of clinical utility, Molecular Oncology, 2008, 1, 4, 384
- 18, , , , Long-term Results of Selective Partial Cystectomy for Invasive Urothelial Bladder Carcinoma, Urology, 2008, 72, 3, 613
- 19, , , , , , , Radiation therapy in urinary cancer: state of the art and perspective, La radiologia medica, 2008, 114, 1, 70
- 20, , , , , , Single Institutional Experience of Bladder-Preserving Trimodality Treatment for Muscle-Invasive Bladder Cancer, Journal of Korean Medical Science, 2008, 23, 4, 598
- 21, , , , , , , Adjuvant androgen deprivation therapy augments cure and long-term cancer control in men with poor prognosis, nonmetastatic prostate cancer, Prostate Cancer and Prostatic Diseases, 2007, 11, 1, 46
- 22
- You have free access to this content23, , , , , , Long-term follow up of patients with invasive bladder carcinoma receiving combined cisplatin-based intra-arterial chemotherapy and radiotherapy, International Journal of Urology, 2007, 14, 7Direct Link:
- 24, , , , , , , Radiochemotherapy With Cisplatin and 5-Fluorouracil After Transurethral Surgery in Patients With Bladder Cancer, International Journal of Radiation Oncology*Biology*Physics, 2007, 68, 4, 1072
- 25
- 26, , , , , , , , , , , , , , , , , , Conservative treatment with transurethral resection, neoadjuvant chemotherapy followed by radiochemotherapy in stage T2-3 transitional bladder cancer, Clinical and Translational Oncology, 2006, 8, 12, 903
- 27, , Neoadjuvant chemotherapy in invasive bladder cancer, Expert Review of Anticancer Therapy, 2005, 5, 6, 993